Besides, FATP5 deficiency activates nrf2/txnrd1 pathway by increasing lipid peroxidation in HCC (Gao et al., 2020), suggesting that FATP5 acts as a novel tumor suppressor in the development of liver cancer and is positive correlation with the prognosis of HCC patients. This evidence concerns the gene TXNRD1 and neoplasm.